City Therapeutics, Inc. (CTY) company profile
CTYNasdaqPharmaceutical PreparationsFiscal year ends December 31
$17.50+0.52 (+3.06%)
Close on Nov 17, 2026Market cap –P/E –Yield –
About City Therapeutics
Pharmaceutical Preparations, SIC 2834
City Therapeutics, Inc. is listed on Nasdaq under the ticker CTY, in the SEC industry Pharmaceutical Preparations. It is incorporated in Delaware and its fiscal year ends on December 31.
Company profile
Company
- Legal name
- City Therapeutics, Inc.
- Headquarters
- Cambridge, MA
- Address
- 399 Binney St 02141
- Phone
- (857) 357-2024
- Website
- citytx.com
- Industry
- Pharmaceutical Preparations
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
Stock & identifiers
- Ticker
- CTY
- Exchange
- Nasdaq
- IPO date
- Oct 16, 2026
- Filer category
- <br>Emerging growth company
- SEC CIK
- 2143850
- CUSIP
- 178782108
- ISIN
- US1787821081
- FIGI
- BBG01Q6VFNB7
- Share class FIGI
- BBG01Q6VFND5
- EIN
- 93-2762122
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Andrew C. Orth | President & CEO, Director | 1,063,154 |
| Tracy Zimmermann | Chief Scientific Officer | – |
| Keith Regnante | Chief Financial Officer | – |
| Baisong Mei | Chief Medical Officer | 228,743 |
| Sebastian Trousil | Chief Operating Officer | 534,511 |
| Barry E. Greene | Director | – |
| John Maraganore | Director | 2,107,706 |
| Sara Nochur | Director | – |
| Robert Nelsen | Director | 13,692,507 |
| Ron M. Philip | Director | – |
IPO
From the final prospectus (Form 424B4) and the first day of trading
Offering
- Type
- Initial public offering
- Final prospectus filed
- Oct 16, 2026
- Offer price
- $18.00
- Securities offered
- 11,111,111
- Gross proceeds
- $200.00M
- Exchange
- Nasdaq
- Lock-up ends (est.)
- Apr 14, 2027
“The initial public offering price per share is $18.00.”
Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Oct 16, 2026 | IPO | Initial public offering priced (424B4 prospectus) |
| Oct 13, 2026 | Listing | Registration of securities on an exchange (Form 8-A) |
See a number that looks wrong?